ClinicalTrials.Veeva

Menu

Model 20105 Lead Study

Medtronic logo

Medtronic

Status

Terminated

Conditions

Sick Sinus Node Syndrome

Treatments

Device: Model 20105

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

The purpose of this study is to evaluate the implant procedure and feasibility of a new lead developed to pace and sense the left chambers of the heart.

Enrollment

16 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject has Cardiac pacing indication for sinus node dysfunction (dual chamber pacemaker)
  • Subject has signed and dated the study-specific informed consent form
  • Subject is 18 years of age or older
  • Subject is willing, able and committed to participate in Baseline and Follow-up and study procedures for the full length of the study

Exclusion criteria

  • Subject is indicated for BiV pacemaker or ICD
  • Subject is pacing dependent
  • Subject has a previous Pacemaker System
  • Subject has known coronary venous vasculature that is inadequate for lead placement
  • Subject has unstable angina pectoris or has had an acute myocardial infarction (MI) within the last month
  • Subject has had a coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) within the past three months
  • Subject is not in sinus rhythm at implant
  • Subject has had a heart transplant (patients waiting for heart transplants are allowed in the study)
  • Subject has known renal insufficiency that would prevent them from receiving an occlusive venogram during the implant procedure
  • Subject is contraindicated for <1mg dexamethasone acetate
  • Subject is enrolled in any concurrent drug and/or device study that may confound the results of this study
  • Subject has a terminal illness and is not expected to survive more than 6 months
  • Subject is a pregnant woman or woman of childbearing potential not on adequate birth control.
  • Subject is employed by Medtronic or by the department of any of the investigators or is a close relative of any of the investigators.
  • Legal incapacity or evidence that a subject cannot understand the purpose and risks of the study
  • Subject meets exclusion criteria required by local law.
  • Subject is unable to tolerate an urgent thoracotomy

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

16 participants in 1 patient group

Model 20105
Experimental group
Description:
Receiving the model 20105 Lead
Treatment:
Device: Model 20105

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems